The Center for Advanced Biotechnology and Medicine (CABM) was founded in 1985 and research started in 1986 to advance knowledge in the life sciences for the improvement of human health. CABM, designated by the New Jersey Commission on Science and Technology as a New Jersey Advanced Technology Center, is located on the Busch/Piscataway campus in a 100,000 square foot building completed in 1990.

CABMWhere Biology Becomes Medicine. Our mission is to make fundamental discoveries in biomedical research, develop new technologies, and translate these to improve human health.

The mission of CABM scientists is focused in four areas:

To perform cutting edge research in the areas of infectious disease, cancer, and neurodevelopmental/neurodegenerative disorders
including AIDS, influenza, leukemia/lymphoma, autism, and metabolic diseases, facilitated by collaboration among
investigators with expertise in different disciplines.

To foster the next generation of biomedical researchers through classroom teaching and laboratory training for undergraduate,
graduate, and medical students as well as postdoctoral fellows and visiting scientists.

To promote economic development through corporate collaborations, consultation, and technology transfer.

To enhance the research environment in New Jersey by providing access to high-end instrumentation, shared facilities,
sophisticated technologies, and international collaborations.

Interim Director
Ann M. Stock, Ph.D.

Matt Leonardelli, MPH, Director of Business Operations
Sally Marshall, Laboratory Manager

Scientific Advisory Board
CABM is advised by a group of distinguished scientific leaders in industry and academia.
Download Members List (PDF): 2012

Annual Report
The report is released yearly and summarizes CABM research, education and training activities, as well as technology transfer and fiscal information.
Download Annual Report (PDF): 20122011200920082007200620052004200320022001